WELL Health Technologies (TSE:WELL) Price Target Raised to C$8.50

WELL Health Technologies (TSE:WELL) had its price objective increased by TD Securities from C$8.00 to C$8.50 in a research note published on Tuesday,BayStreet.CA reports.

A number of other equities analysts have also recently issued reports on the stock. Ventum Financial cut their price objective on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th. Haywood Securities lifted their price target on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday, December 13th. Scotiabank upped their price target on WELL Health Technologies from C$6.00 to C$7.00 in a research report on Monday. Finally, CIBC lifted their target price on shares of WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday, December 13th.

WELL Health Technologies Trading Up 1.4 %

TSE WELL opened at C$7.09 on Tuesday. The company has a market cap of C$1.77 billion, a price-to-earnings ratio of 12.44, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. The business’s fifty day moving average is C$5.24 and its 200 day moving average is C$4.73. WELL Health Technologies has a twelve month low of C$3.41 and a twelve month high of C$7.17.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.